Summary
Toll-like receptors (TLRs) recognize specific pathogen-associated molecular patterns (PAMPs), which subsequently trigger innate immunity. Recent data also suggest a role for TLRs in the direct activation of adaptive immune cells. In the present study, the expression and function of TLR1-TLR10 were characterized in purified human tonsillar 
Introduction
The Toll-like receptor (TLR) family consists of 10 members (TLR1-TLR10) [1] , which are transmembrane proteins with an extracellular leucine-rich domain and a conserved cytoplasmic domain. The cytoplasmic domain is homologous to the interleukin (IL)-1 receptor and is referred to as the Toll/IL-1 receptor (TIR) domain [2] [3] [4] . Each TLR recognizes specific microbial components, so called pathogen-associated molecular patterns (PAMPs) [5] , including bacterial lipoproteins and lipoteichoic acids (TLR2), double-stranded viral RNA (dsRNA; TLR3), lipopolysaccharides (LPS; TLR4), flagellin (TLR5), imidazoquinolines and single-stranded viral RNA (ssRNA; TLR7 and TLR8) and unmethylated CpG oligodeoxynucleotides (ODNs; TLR9) [1, 4, [6] [7] [8] . TLR1
and TLR6 only signal as a dimer when combined with TLR2 [9] , and the ligand for
TLR10 is yet unknown [2] . TLRs are differentially expressed in various immune cells.
In general, mononuclear phagocytes and dendritic cells (DCs) express the widest TLR repertoires [10] . Recognition of PAMPs by innate immune cells results in a signalling pathway that leads to antigen presentation, up-regulation of costimulatory molecules and release of cytokines, which in turn stimulates the adaptive immune system consisting of B and T lymphocytes [9] [10] [11] . In addition to this indirect activation of B cells, it is also speculated in whether infectious organisms can directly activate the adaptive immune response [10, 12] . 
Materials and Methods

Patients
Tonsils were obtained from 33 children undergoing tonsillectomy at Malmö University Hospital (Malmö, Sweden). The study was approved by the Ethics Committee of Lund University and written informed consent was obtained. After the tonsillectomy, swabs were taken for tonsillar core cultures (representing the microbial flora of the tonsillar crypts) in order to determine the presence of pathogenic β-haemolytic streptococci and anaerobes. The patients providing the tonsils were divided into two groups, referred to as infected or control, based on their clinical diagnoses and the outcome of the core culture. The infected group consisted of 14 patients (age range: 3-21 years, median 7 years) referred to tonsillectomy because of multiple episodes (at least four times during the year preceding the surgery) of group A β-haemolytic streptococci (GAS) tonsillitis (small to substantially enlarged tonsils, positive cultivation test). The control group consisted of 19 patients (age range: 3-18 years, median 6.5 years) who underwent tonsillectomy because of tonsillar hyperplasia indicated by either obstructive sleep apnoea or occasional failure to thrive (no history of recurrent tonsillitis, negative cultivation test). Even though the control tonsils were culture-negative and functioned as appropriate controls in regard to infection, they were not normal healthy tissues.
Therefore, it cannot be entirely excluded that there is some immunological relevant cause of the hyperplasia that affected the outcome of the present study. None of the patients displayed symptoms of acute infection at the time of surgery, and none of them had received any antibiotic treatment for at least one month prior to surgery. Apart from the tonsillar symptoms, all patients were healthy and did not receive any medication.
Antibodies and reagents
The following anti-human Abs were used for flow cytometry analyses: CD19-ECD by FACS, and IL-6 was measured in the cell-free supernatants by ELISA.
RNA isolation and real-time RT-PCR
Freshly isolated cells were lysed in RLT buffer (Qiagen, Hilden, Germany)
supplemented with 1% 2-merkaptoethanol and stored in -80°C until use. RNA was extracted using RNeasy Mini Kit (Qiagen). The quantity and quality of the RNA concentration was determined by spectrophotometry based on the A 260 /A 280 ratio.
Omniscript Reverse Transcriptase kit (Qiagen) and oligo(dT) 15 formaldehyde and permeabilized in PBS containing 0.1% Triton X 100. PBS supplemented with 2% FCS was used for all labelling and washing steps.
Immunohistochemistry
The morphological localisation of TLR proteins in tonsils was investigated using 
Cytokine detection by ELISA
Cell-free culture supernatants were assayed for IL-6 (sensitivity 3.12-300 pg/ml) using ELISA plates from R&D Systems (Minneapolis, MN).
Statistical analyses
Statistical analysis was performed using GraphPad Prism 4 (GraphPad, San Diego, CA 
Expression pattern of TLR1-TLR10 in subsets of human tonsil B cells
The expression of TLR1-TLR10 transcripts was analysed using quantitative real-time RT-PCR, and all data are presented in relation to the housekeeping gene β-actin. B cells expressed several TLRs, and among them TLR1, TLR7, TLR9 and TLR10 were most prominent ( Fig. 2A) . Expression of TLR2 was low, and TLR6 was expressed at the lower detection limit, whereas TLR3, TLR4, TLR5 and TLR8 were undetectable.
Unlike previous studies, mainly performed on PB but also tonsils, showing the presence of TLR1 and TLR6-TLR10 mRNA [21] , we failed to detect TLR6 and TLR8. To investigate whether this discrepancy was due to tissue-specific factors, mRNA was extracted from PB B cells and analysed for TLR1-TLR10 expression. As for tonsillar B cells, no expression of TLR6 or TLR8 could be detected ( Fig. 2A) . However, expression of TLR7 was higher in blood-derived B cells, whereas TLR9 was considerably lower compared with tonsillar cells.
Next, we wished to investigate whether the TLR expression was altered during the different stages in the B cell development. The TLR expression in purified subsets of naïve, GC and memory B cells was compared. The three subsets of cells were found to express the detected TLRs constitutively (Fig. 2B) , and similar levels of TLR1, TLR2
and TLR10 were expressed by each of the cell subsets. TLR7 and TLR9 were also present in the three subsets, albeit somewhat higher in memory B cells. Neither of these differences did however reach statistical significance.
To determine whether the observed mRNA expression pattern actually reflected the functional TLR proteins expressed, flow cytometry and immunohistochemistry were carried out on the TLRs that were transcriptionally expressed. Highly purified CD19 + B cells were stained with Abs against CD19, TLR1, TLR2, TLR7 and TLR9 (no Ab against TLR10 was commercially available) and analysed by FACS. The cells clearly displayed the receptor proteins, thus verifying the presence of the TLRs (Fig. 3) .
Immunohistochemical staining of tonsils with Abs against the B and T cells markers CD20 and CD3, respectively, as well as against TLR1, TLR2, TLR7 and TLR9, was performed to identify the cellular location of the receptors. CD20 + cells were as expected localized mainly within the GCs, whereas CD3 + cells predominantly resided in the T cell zones (Fig. 4A,B) . Cells expressing TLR1, TLR7 and TLR9 were abundant in the GCs, but also present in the adjacent T cell zones, whereas expression 14 of TLR2 was more intense in the T cell zones (Fig. 4C-F) . The presence of the TLR proteins in the GCs also confirms the presence of the TLR transcripts in B cells.
Influence of tonsillar infection on the TLR expression pattern
It has previously been described that TLR ligands, such as bacterial and viral components, found at sites of infection or inflammation affect the expression of their cognate TLRs [22] . Tonsils indeed are a site of high antigenic burden, being continuously exposed to bacteria, viruses, fungi and other inhaled or ingested substances [23] . This led us to compare the expression of TLR mRNA in cells from recurrently infected tonsils with that from non-infected, hyperplastic tonsils that served as controls. In the infected tonsils, several strains of bacteria were found, including β-haemolytic streptococci (group A, C and G) and anaerobes. In general, the expression of TLRs in naïve and GC B cells was higher in cells from infected tonsils, whereas it was the other way around in memory B cells (Fig. 5) . The only significant difference was that TLR10 was up-regulated in naïve B cells from infected tonsils. In GC B cells there was also a trend towards a higher expression of TLR10 in cells from infected tonsils compared to control, although not significant. In memory B cells the relationship was reversed. encoding primarily TLR1 and TLR6-TLR10 [21] . The present study largely confirms the existing transcriptional data, but also extends and complements these results on protein level, demonstrating the presence of TLR1, TLR2, TLR7 and TLR9 using FACS analysis. The protein level of TLR2 was quite high in contrast to the mRNA expression level. Similar discrepancies when TLR mRNA and protein disconnect have previously been reported for human leukocytes [1, 25] . Although the PCR techniques used today are very sensitive, they do not provide definite proofs of the presence of TLRs [26] . Measuring transcribed mRNA alone is clearly not sufficient to characterize the TLR repertoire, which underscores the importance in analysing protein expression and ultimately functional activity. In contrast to most studies performed on PB [21, 22, 27] , we failed to detect TLR6 and TLR8 in tonsils. As this suggested that TLR expression might be regulated by tissue-specific factors, we also investigated the expression of TLRs in B cells from PB. Expression of both TLR6 and TLR8 was, however, still lacking, indicating that the differences in TLR expression profiles are caused by variations from one study to another.
Herein, we isolated naïve, GC and memory B cells based on the expression of CD19, IgD, CD38 and CD27. CD27 has been defined as a marker for somatically mutated B cells [28] , in tonsil comprising memory B cells and a portion of the GC B cells. Thus, (TLR6, TLR7 , TLR9 and TLR10) followed by an up-regulation during the differentiation into memory cells [27] . It is important to recognize here the functional differences between B cells from PB and secondary lymphoid tissues like tonsils. It is well known that blood lacks GC B cells and contains a larger percentage resting B cells compared to tonsils [29] . In addition, our data clearly show that TLR9 is expressed to a greater extent in B cells from tonsils than PB, whereas expression of TLR7 is higher in PB. Naïve and memory cells moving from a resting state are thought to induce a general increase in TLR expression when they are activated and re-enter the cell cycle probably because the plateau of the concentration-response curve was not reached. A recent study, using the imidazoquinoline R-848 (agonist for both TLR7 and TLR8, structurally related to R-837) and loxoribine (selective TLR7 ligand), showed that purified human B cells were unable to respond to both R-848 and loxoribine unless they were cocultured with plasmacytoid dendritic cells (PDCs) or PDC-derived type I interferons (IFNs) [24] . The same group showed that Pam 3 CSK 4 was incapable of activating human B cells, both in the absence or presence of PDCs. Another group reported that both imiquimod and R-848 induced proliferation, Ig secretion and upregulation of MHC class II and B7.2 in murine B cells [35] . They further demonstrated that human B cells isolated from PBMC were induced to proliferate in response to R-20 848 (no data available for R-837). In another study, human CD19 + B cells from PB did not respond markedly when exposed to imiquimod or R-848 [36] . Furthermore, LPS and flagellin showed no B cell activating ability, which is an expected finding given the absence of TLR4 and TLR5 expression. Contrasting data have, however, recently been presented in a study by Pasare and Medzhitov [37] . They showed that TLR4 and TLR5
signalling in B cells is required for the induction of optimal antibody responses to Tdependent antigens in mice. However, species-related differences clearly exist [21, 24] . (1:50) and (F) TLR9 (1:50) were localized using 3,3'-diaminobenzidine (DAB), which stains tissues brown, and analysed by microscopy (magnification ×40-100). 
